Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News

More articles from Epigenetic Cancer Therapies

  • Abstract B42: Decitabine specifically targets genes that gain DNA methylation and lose expression in cancer and can be combined with histone methylation inhibitors for increased efficacy
    Takahiro Sato, Matteo Cesaroni, Anthony Tran, Jozef Madzo, Yasuyuki Okamoto, Hanghang Zhang, Shoghag Panjarian, Jaroslav Jelinek, Jean-Pierre Issa
    Cancer Research Jan 2016, 76 (2 Supplement) B42; DOI: 10.1158/1538-7445.CHROMEPI15-B42
  • Abstract IA27: Tazemetostat, an EZH2 inhibitor and potential therapeutic for non-Hodgkin lymphoma
    Jesse J. Smith
    Cancer Research Jan 2016, 76 (2 Supplement) IA27; DOI: 10.1158/1538-7445.CHROMEPI15-IA27
  • Abstract B39: BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia
    Sofie Peirs, Filip Matthijssens, Tim Pieters, Niels Vandamme, Geert Berx, Bruce Poppe, Pieter Van Vlierberghe
    Cancer Research Jan 2016, 76 (2 Supplement) B39; DOI: 10.1158/1538-7445.CHROMEPI15-B39
  • Abstract PR10: A DNA hypomethylation signature predicts novel antitumor activity of LSD1 inhibition in SCLC
    Helai Mohammad, Ryan Kruger
    Cancer Research Jan 2016, 76 (2 Supplement) PR10; DOI: 10.1158/1538-7445.CHROMEPI15-PR10
  • Abstract B40: WEE1 inhibition selectively kills histone H3K36me3-deficient cancers by dNTP starvation
    Sophia X. Pfister, Enni Markkanen, Yanyan Jiang, Sovan Sarkar, Mick Woodcock, Lykourgos-Panagiotis Zalmas, Giulia Orlando, Neele Drobnitzky, Grigory Dianov, Songmin Ying, Nicholas B. La Thangue, Vincenzo D'Angiolella, Anderson Ryan, Timothy C. Humphrey
    Cancer Research Jan 2016, 76 (2 Supplement) B40; DOI: 10.1158/1538-7445.CHROMEPI15-B40
  • Abstract IA23: Multiple targetable pathways for epigenetic therapy
    Jean-Pierre J. Issa
    Cancer Research Jan 2016, 76 (2 Supplement) IA23; DOI: 10.1158/1538-7445.CHROMEPI15-IA23
  • Abstract B51: The pan deacetylase inhibitor panobinostat shows cytotoxic activity as monotherapy and synergism with topoisomerase inhibitors in cervical cancer cells
    Lubna Wasim, Madhu Chopra
    Cancer Research Jan 2016, 76 (2 Supplement) B51; DOI: 10.1158/1538-7445.CHROMEPI15-B51
  • Abstract B30: Targeting EZH2 methyltransferase activity: A novel therapeutic approach to ARID1A-deficient cancer
    Benjamin Bitler, Azat Garipov, Ie Ming Shih, Rugang Zhang
    Cancer Research Jan 2016, 76 (2 Supplement) B30; DOI: 10.1158/1538-7445.CHROMEPI15-B30
  • Abstract B50: A phenotypic screen to identify novel potential epigenetic anticancer drugs from natural compounds
    Hanghang Zhang, Noël J.-M Raynal, Takahiro Sato, Yasuyuki Okamoto, Benjamin Garcia, George Morton, Wayne Childers, Marlene A. Jacobson, Stephen B. Baylin, Magid Abou-Gharbia, Jean-Pierre J. Issa
    Cancer Research Jan 2016, 76 (2 Supplement) B50; DOI: 10.1158/1538-7445.CHROMEPI15-B50
  • Abstract B43: Dose and context-dependent roles for Arid1a in liver tumorigenesis
    Xuxu Sun, Sam Wang, Liem Nguyen, Hao Zhu
    Cancer Research Jan 2016, 76 (2 Supplement) B43; DOI: 10.1158/1538-7445.CHROMEPI15-B43

Pages

  • Next
  • 1
  • 2
  • 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement